Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis

Background/Aims The global proportion of hepatocellular carcinoma (HCC) attributable to metabolic dysfunction-associated fatty liver disease (MAFLD) is unclear. The MAFLD diagnostic criteria allows objective diagnosis in the presence of steatosis plus defined markers of metabolic dysfunction, irresp...

Description complète

Détails bibliographiques

Auteurs principaux:	Harry Crane, Guy D. Eslick, Cameron Gofton, Anjiya Shaikh, George Cholankeril, Mark Cheah, Jian-Hong Zhong, Gianluca Svegliati-Baroni, Alessandro Vitale, Beom Kyung Kim, Sang Hoon Ahn, Mi Na Kim, Simone I Strasser, Jacob George
Format:	Artigo
Langue:	Inglês
Publié:	Korean Association for the Study of the Liver 2024-07-01
Collection:	Clinical and Molecular Hepatology
Sujets:	fatty liver hepatocellular carcinoma epidemiology prevalence metabolic syndrome
Accès en ligne:	http://e-cmh.org/upload/pdf/cmh-2024-0109.pdf
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!